People taking FDA-approved doses of Wegovy for one year and four months lost about 35 pounds, according to the manufacturer
Since these drugs have been ins short supply, the manufacturers have little incentive to negotiate lower net prices
Mounjaro was tested over 72 weeks with the following results: Those taking 5mg lost 16% of their starting weight Those taking 10mg lost 21.4% of their starting weight Those taking 15mg lost 22.5% of their starting weight Wegovy was tested over 68 weeks with people losing 15% or more of their starting weight at the maintenance dose of 2.4mg
Each plan is paired with supportive coaching for nutrition and lifestyle to encourage total wellness
Blood samples were processed to either plasma (LDL-C analysis) or serum (human Fc, free PCSK9 and GLP-1R active compound analysis)
10.1016/S2213-8587(19)30422-X Summary Keywords GLP-1 receptor agonists, diabetes, coronary artery disease, acute and chronic coronary syndromes, atherosclerosis, coronary microcirculation Citation Pahud de Mortanges A, Sinaci E, Salvador Jr D, Bally L, Muka T, Wilhelm M and Bano A (2022) GLP-1 Receptor Agonists and Coronary Arteries: From Mechanisms to Events
